Related Articles
Study provides further evidence in favor of Gamma Knife radiosurgery as frontline treatment in patients with 4+ brain mets – Gamma Knife SRS known for lower toxicity/side effects and fewer treatment sessions – Potential to treat and retreat a patient with Gamma Knife over a long time period Clinicians at 23 Japanese medical centers continued…
Among the world’s most prolific users of Leksell Gamma Knife® Icon™, Samsung Medical Center (SMC, Seoul) has set an industrious pace of about 18 patient treatments per week since the system was installed in January 2016….
Living up to its name and reputation, The Brain Centre (Hong Kong) upgraded its Gamma Knife® system in June 2016 to Leksell Gamma Knife® Icon™, refining and expanding its Gamma Knife radiosurgery capabilities. Today, frameless fractionated radiosurgery with Icon – maintaining the extreme accuracy for which frame-based Gamma Knife® radiosurgery is renowned – is benefitting…
Appreciating that Leksell Gamma Knife® Icon™ represents the quintessential platform for performing intracranial stereotactic radiosurgery (SRS), clinicians at Universitätsmedizin Mannheim (UMM) set about in 2014 to incorporate the technology into their well-equipped radiation therapy department. SRS, a stable treatment technique at UMM since 2001, had been delivered exclusively via linear accelerator for all intracranial cases…
Thrilling ups and downs, rapid turns and hard crashes are all part of life. Sometimes things take a smooth, predictable approach and other times you get caught in a tailspin from out of nowhere that slams you hard on the concrete. It’s not really about how hard you fall, but more about how quickly you…
Radiotherapy of spinal metastases to help patients suffering from debilitating pain is among the most technically challenging treatments to execute. To avoid dosing the spinal cord, clinicians must do several things proficiently: patient immobilization, lesion characterization, treatment planning, beam shaping (i.e., targeting) and detection of, and accounting for, intrafraction motion. To maintain the submillimeter/subdegree precision…
As a leading innovator of precision radiation therapy solutions, Elekta is committed to ensuring that every patient has access to the best cancer care possible.
The products and product clinical indications for use described within FOCUS may not have clearance or registration in certain countries. Please consult Elekta in your country for questions concerning a product or clinical use subject. This site may contain information provided by third party sources to Elekta that does not necessarily represent the views of Elekta. Individuals interviewed provided information based on their personal experience and were not compensated for their participation. Accordingly, third party information contained in this site is provided "as is" with no guarantees of completeness, accuracy, usefulness, or timeliness.
© 2022 Elekta | FOCUS Magazine. | Privacy Policy | Cookies
